.png){kind=icon}
.png){kind=icon}
Return
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial
.png){kind=icon}
OA
AI
DOI：10.1016/j.jtho.2026.104071.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Tobacco cessation support should be offered to all participants with active tobacco use within lung cancer (LC) screening programs. Among the pharmacologic options, cytisine is effective and safe, although data in individuals aged ≥65 years remain limited.
Keywords:
lung cancer screening
cytisine
tobacco quitting programs
Journal
IF:
20.8
Papers:
757
Citations:
2.7W
Organization
View more organizations